| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |